AU2002238947A1 - Triazaspiro[5.5]undecane derivatives and drugs containing the same as the active ingredient - Google Patents

Triazaspiro[5.5]undecane derivatives and drugs containing the same as the active ingredient

Info

Publication number
AU2002238947A1
AU2002238947A1 AU2002238947A AU2002238947A AU2002238947A1 AU 2002238947 A1 AU2002238947 A1 AU 2002238947A1 AU 2002238947 A AU2002238947 A AU 2002238947A AU 2002238947 A AU2002238947 A AU 2002238947A AU 2002238947 A1 AU2002238947 A1 AU 2002238947A1
Authority
AU
Australia
Prior art keywords
triazaspiro
same
active ingredient
drugs containing
undecane derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002238947A
Other versions
AU2002238947B2 (en
Inventor
Hiromu Habashita
Shin-Ichi Hamano
Shiro Shibayama
Yoshikazu Takaoka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ono Pharmaceutical Co Ltd
Original Assignee
Ono Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co Ltd filed Critical Ono Pharmaceutical Co Ltd
Priority claimed from PCT/JP2002/002554 external-priority patent/WO2002074770A1/en
Publication of AU2002238947A1 publication Critical patent/AU2002238947A1/en
Application granted granted Critical
Publication of AU2002238947B2 publication Critical patent/AU2002238947B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002238947A 2001-03-19 2002-03-18 Triazaspiro[5.5]undecane derivatives and drugs containing the same as the active ingredient Ceased AU2002238947B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2001-79610 2001-03-19
JP2001079610 2001-03-19
JP2001160251 2001-05-29
JP2001-160251 2001-05-29
PCT/JP2002/002554 WO2002074770A1 (en) 2001-03-19 2002-03-18 Triazaspiro[5.5]undecane derivatives and drugs containing the same as the active ingredient

Publications (2)

Publication Number Publication Date
AU2002238947A1 true AU2002238947A1 (en) 2003-03-27
AU2002238947B2 AU2002238947B2 (en) 2007-10-18

Family

ID=26611613

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002238947A Ceased AU2002238947B2 (en) 2001-03-19 2002-03-18 Triazaspiro[5.5]undecane derivatives and drugs containing the same as the active ingredient

Country Status (23)

Country Link
US (2) US7053090B2 (en)
EP (2) EP1378510B1 (en)
JP (1) JP3558079B2 (en)
KR (1) KR100714154B1 (en)
CN (1) CN1291988C (en)
AT (1) ATE328884T1 (en)
AU (1) AU2002238947B2 (en)
BR (1) BR0208167A (en)
CA (1) CA2440264A1 (en)
CZ (1) CZ20032531A3 (en)
DE (1) DE60212110T2 (en)
DK (1) DK1378510T3 (en)
ES (1) ES2266452T3 (en)
HU (1) HUP0400229A2 (en)
IL (1) IL157819A0 (en)
MX (1) MXPA03008529A (en)
NO (1) NO20034148L (en)
NZ (1) NZ528249A (en)
PL (1) PL364427A1 (en)
PT (1) PT1378510E (en)
RU (1) RU2269528C2 (en)
TW (1) TWI254047B (en)
WO (1) WO2002074770A1 (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03008528A (en) * 2001-03-19 2004-06-30 Ono Pharmaceutical Co Drugs containing triazaspiro[5.5]undecane derivatives as the active ingredient.
BR0314304A (en) * 2002-09-18 2005-07-26 Ono Pharmaceutical Co Triazapiro Drugs and Derivatives [5.5] undecane comprising the same as the active ingredient
TW200413371A (en) * 2002-09-18 2004-08-01 Ono Pharmaceutical Co Novel crystal of triazaspiro [5.5]undecane derivatives
WO2004054616A1 (en) * 2002-12-13 2004-07-01 Ono Pharmaceutical Co., Ltd. Antagonist and agonist binding to strong binding site of chemokine receptor
ATE405269T1 (en) * 2002-12-13 2008-09-15 Smithkline Beecham Corp CYCLOHEXYL COMPOUNDS AS CCR5 ANTAGONISTS
US7271172B2 (en) * 2002-12-13 2007-09-18 Smithkline Beecham Corporation Pyrrolidine and azetidine compounds as CCR5 antagonists
WO2004080966A1 (en) 2003-03-14 2004-09-23 Ono Pharmaceutical Co., Ltd. Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient
WO2004092169A1 (en) * 2003-04-18 2004-10-28 Ono Pharmaceutical Co., Ltd. Spiropiperidine compound and medicinal use thereof
US20070155713A1 (en) * 2003-04-21 2007-07-05 Rena Nishizawa Nitrogen-containing heterocyclic compounds and use thereof
US20070270429A1 (en) * 2003-05-06 2007-11-22 Shiro Shibayama Function Inhibitor of Effector Cell
EP1790639B1 (en) 2004-08-27 2014-03-26 Ono Pharmaceutical Co., Ltd. Spirocyclic compounds and their use as cxcr4-antagonists
MX2007002886A (en) 2004-09-13 2007-05-16 Ono Pharmaceutical Co Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient.
US8680092B2 (en) 2005-02-25 2014-03-25 Ono Pharmaceutical Co., Ltd. Nitrogenous heterocyclic compound and medicinal use thereof
WO2006115833A1 (en) 2005-04-20 2006-11-02 Merck & Co., Inc. Benzothiophene hydroxamic acid derivatives with carbamate, urea, amide and sulfonamide substitutions
US7772238B2 (en) 2005-04-20 2010-08-10 Merck Sharp & Dohme Corp. Benzothiophene hydroxamic acid derivatives
EP1874295A4 (en) 2005-04-20 2009-08-12 Merck & Co Inc Benzothiophene derivatives
WO2006129679A1 (en) 2005-05-31 2006-12-07 Ono Pharmaceutical Co., Ltd. Spiropiperidine compound and medicinal use thereof
EP1896395B1 (en) 2005-06-24 2015-07-15 Merck Sharp & Dohme Corp. Modified malonate derivatives
US8168783B2 (en) 2005-11-18 2012-05-01 Ono Pharmaceutical Co., Ltd. Chemokine receptor antagonists and use thereof
AR057579A1 (en) 2005-11-23 2007-12-05 Merck & Co Inc SPIROCICLICAL COMPOUNDS AS INHIBITORS OF ACETYLASE HISTONE (HDAC)
US8168658B2 (en) 2006-02-28 2012-05-01 Merck Sharp & Dohme Corp. Inhibitors of histone deacetylase
CA2644368A1 (en) 2006-03-10 2007-09-20 Ono Pharmaceutical Co., Ltd. Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient
EP2013196B1 (en) 2006-04-26 2015-09-16 Merck Sharp & Dohme Corp. Disubstituted aniline compounds
WO2007132846A1 (en) 2006-05-16 2007-11-22 Ono Pharmaceutical Co., Ltd. Compound having acidic group which may be protected, and use thereof
CA2651681A1 (en) 2006-05-18 2007-11-29 Merck & Co., Inc. Aryl-fused spirocyclic compounds
WO2008010985A2 (en) 2006-07-20 2008-01-24 Merck & Co., Inc. Phosphorus derivatives as histone deacetylase inhibitors
WO2009002495A1 (en) 2007-06-27 2008-12-31 Merck & Co., Inc. 4-carboxybenzylamino derivatives as histone deacetylase inhibitors
CA2692153A1 (en) 2007-06-27 2009-01-08 Richard W. Heidebrecht, Jr. Pyridyl and pyrimidinyl derivatives as histone deacetylase inhibitors
WO2010009196A1 (en) * 2008-07-15 2010-01-21 Temple University Of The Commonwealth System Of Higher Education Synthesis of bis-peptides oligomers comprising at least one n-substituted diketopiperazine as structural moiety
RU2455284C1 (en) * 2011-03-15 2012-07-10 Государственное образовательное учреждение высшего профессионального образования "Пермский государственный университет" Method of producing 5-aryl-2-methyl-1,3-dioxo-2-azaspiro[5,5] undecane-4-carbonitriles and agent exhibiting analgesic activity
TW202110844A (en) * 2019-06-04 2021-03-16 日商第一三共股份有限公司 Dispiro-diketopiperazine compounds
RU2752079C1 (en) * 2020-12-01 2021-07-22 Федеральное государственное автономное образовательное учреждение высшего образования "Пермский государственный национальный исследовательский университет" (e)-(6-(2-hydroxyphenyl)-2-iminio-4,7,8-trioxo-1,3-diphenyl-1,3,6-triazaspiro[4.4]nonan-9-ylidene)(4-methoxyphenyl)methanoate with antimicrobial activity and its preparation method

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997011940A1 (en) * 1995-09-29 1997-04-03 Eli Lilly And Company Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation
WO1998025605A1 (en) * 1996-12-13 1998-06-18 Merck & Co., Inc. Spiro-substituted azacycles as modulators of chemokine receptor activity
EP1003743A4 (en) 1997-01-21 2001-04-11 Merck & Co Inc 3,3-disubstituted piperidines as modulators of chemokine receptor activity
US6288083B1 (en) * 1998-09-04 2001-09-11 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
NZ519183A (en) 1999-12-03 2005-02-25 Ono Pharmaceutical Co Triazaspiro[5.5]undecane derivatives and pharmaceutical compositions comprising thereof, as an active ingredient
MXPA03008528A (en) 2001-03-19 2004-06-30 Ono Pharmaceutical Co Drugs containing triazaspiro[5.5]undecane derivatives as the active ingredient.

Similar Documents

Publication Publication Date Title
AU2002238947A1 (en) Triazaspiro[5.5]undecane derivatives and drugs containing the same as the active ingredient
IL157940A0 (en) Drugs containing triazaspiro [5.5] undecane derivatives as the active ingredient
PL376154A1 (en) Triazaspiro[5.5]undecane derivatives and drugs comprising the same as the active ingredient
AU3076700A (en) 2h-phthalazin-1-one derivatives and drugs comprising these derivatives as the active ingredient
AU2300699A (en) Amidino derivatives and drugs containing the same as the active ingredient
AU7962200A (en) Novel indole derivatives and drugs containing the same as the active ingredient
AU2002226674A1 (en) Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as the active ingredient
AU2002251546A1 (en) Pyrazolo[1,5-A]pyridines and medicines containing the same
AU2002354054A1 (en) Spiroheterocyclic derivative compounds and drugs comprising the compounds as the active ingredient
AU3053199A (en) Fused thiophene derivatives and drugs containing the same as the active ingredient
IL156536A0 (en) Pyrazolo [3,4-d] pyrimidin-4-one derivatives and pharmaceutical compositions containing the same
AU2002238855A1 (en) N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same
ZA200007415B (en) Amino acid derivatives and drugs containing the same as the active ingredient.
AU6309698A (en) Drugs containing aminopyridine derivatives as the active ingredient
AU5647199A (en) Carboxylic acid derivatives and drugs containing the same as the active ingredient
AU3078000A (en) Heterocyclic compounds and antitumor agents containing the same as the active ingredient
AU2001277738A1 (en) Piperidine derivatives and drugs containing these derivatives as the active ingredient
AU1650401A (en) Oxadiazole derivatives and drugs containing these derivatives as the active ingredient
AU2002333373A1 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
AU5443499A (en) Carboxylic acid derivatives and drugs containing the same as the active ingredient
AU3669700A (en) 4-aminobutanoic acid derivatives and drugs containing these derivatives as the active ingredient
AU1650501A (en) 1,3,4-oxadiazoline derivatives and drugs containing these derivatives as the active ingredient
AU2001228810A1 (en) Benzene-fused heterocycle derivatives and drugs containing the same as the active ingredient
AU2001294240A1 (en) 2,2-diphenylbutanamide derivatives and medicines containing the same
AU2023801A (en) Dihalopropenyloxybenzene derivatives and pesticides containing the same as the active ingredient